CLINICAL_TRIALS
trial_result
· 2025-12-02
Clinical Trial Update: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Summary
A Phase 2 study of LY3454738 in adults with moderate-to-severe Atopic Dermatitis was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED | Results posted: 2025-12-02